Endovascular stent implantation was introduced to femoropopliteal procedures almost two
decades ago. Initial results with balloon-expandable stainless steel stents and self …

The current evolution towards treating more complex femoropopliteal lesions as seen in the
renewed TASC II recommendations clearly reflects the continuous evolutions in …

Endovascular stent implantation was introduced to femoropopliteal procedures almost 2
decades ago. Initial results with balloon-expandable stainless steel stents and self …

Objective The aim of the study was to investigate long-term incidence of stent fractures and
patency after femoropopliteal stenting. Methods Sixty consecutive patients (mean age 70±7 …

Drug-eluting stent (DES) technology was developed to prevent early thrombosis and late
luminal loss to potentially improve long-term patency rates. Although favorable DES results …

Purpose: To determine and compare the rates of in-stent restenosis, late clinical
deterioration, and stent fractures in nitinol stents versus Wallstents implanted for suboptimal …

Although evidence supports that the performance of drug coated balloons seems to be
lesion complexity independent, it is quite clear that in long lesions, severe calcified lesions …

Background: With the aim lo establish the long-term value of stenting long superiicial
femoral artery (SFA) lesions, the data of four German high-volume centers were …

Bioresorbable stents or scaffolds are a new technology in the treatment of coronary and
peripheral vascular disease. Their goal is to provide adequate support to the dilated vessel …

The superficial femoral artery (SFA) is a common site of atherosclerosis and peripheral
vascular disease. Many times this disease can be treated with medical management alone; …